Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 325 of 3173 entries
View as:

A Study to Assess the Safety, Tolerability, and Immunogenicity of RSVpreF in Older Adults in Korea

Phase: N/A Priority: Normal
NCT ID: NCT06593587 Org: User:
Start: 10/07/24 End: 02/03/25 Due: 02/03/26

A First-in-human Study of Multiple Doses of Topically Administered PF-07295324 and PF-07259955

Phase: N/A Priority: Normal
NCT ID: NCT05206604 Org: User:
Start: 02/09/22 End: 08/12/22 Due: 08/12/23

Vaginal Heat Wash-out (HWO) in 4 Groups of Women (Pre- and Postmenopausal With and Without Female Sexual Arousal Disorder (FSAD)).

Phase: N/A Priority: Normal
NCT ID: NCT00443248 Org: User:
Start: 03/31/07 End: 10/31/08 Due: 10/31/09

A Study of Ibuprofen 250 mg / Acetaminophen 500 mg Comparing The Antipyretic Effects in Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02761980 Org: User:
Start: 12/06/16 End: 12/06/17 Due: 12/06/18

Study to Evaluate the Safety and Immunogenicity of a Multivalent Pneumococcal Vaccine Given With Prevnar 13 in Healthy Infants

Phase: N/A Priority: Normal
NCT ID: NCT03550313 Org: User:
Start: 06/01/18 End: 11/05/20 Due: 11/05/21

Six Month Clinical Trial Assessing Efficacy And Safety Of Inhaled Insulin In Type 1 Diabetes Mellitus.

Phase: N/A Priority: Normal
NCT ID: NCT00424437 Org: User:
Start: 09/30/99 End: 09/30/00 Due: 09/30/01

Safety, Toleration and Efficacy of Single Inhaled Doses of PF-00610355 in Chronic Obstructive Pulmonary (COPD) Patients.

Phase: N/A Priority: Normal
NCT ID: NCT00783406 Org: User:
Start: 10/31/08 End: 03/31/09 Due: 03/31/10

First Safety Study in Humans of a Single Dose of CPG 52364

Phase: N/A Priority: Normal
NCT ID: NCT00547014 Org: User:
Start: 09/30/07 End: 04/30/08 Due: 04/30/09

Pharmacokinetic Study of Aztreonam-Avibactam in Severe Renal Impairment

Phase: N/A Priority: Normal
NCT ID: NCT04486625 Org: User:
Start: 08/10/20 End: 10/18/21 Due: 10/18/22

Study Of Letrozole With Or Without Palbociclib (PD-0332991) For The First-Line Treatment Of Hormone-Receptor Positive Advanced Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00721409 Org: User:
Start: 09/15/08 End: 12/20/17 Due: 12/20/18

A Study To Investigate Safety And Pharmacokinetics Of A Single Dose Of PF-00868554 (Filibuvir) In Japanese Healthy Adult Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01051232 Org: User:
Start: 02/28/10 End: 04/30/10 Due: 04/30/11

Enzalutamide vs. Abiraterone in Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer (mCRPC)

Phase: N/A Priority: Normal
NCT ID: NCT05520138 Org: User:
Start: 08/29/22 End: 06/30/23 Due: 06/30/24

Javelin Parp Medley: Avelumab Plus Talazoparib In Locally Advanced Or Metastatic Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT03330405 Org: User:
Start: 10/19/17 End: 01/04/23 Due: 01/04/24

A Study To Investigate Whether PF-04457845 Is Effective In Treating Pain, Is Safe And Tolerable In Patients With Osteoarthritis Of The Knee

Phase: N/A Priority: Normal
NCT ID: NCT00981357 Org: User:
Start: 11/30/09 End: 05/31/10 Due: 05/31/11

A Single Dose Study In Japanese And Western Healthy Subjects To Investigate The Safety, Tolerability And Pharmacokinetics Of PF-04991532

Phase: N/A Priority: Normal
NCT ID: NCT01369277 Org: User:
Start: 06/30/11 End: 09/30/11 Due: 09/30/12

Study Evaluating Inotuzumab Ozogamicin [CMC-544] Administered In Combination With Rituximab In Subjects With Non-Hodgkin's Lymphoma (NHL)

Phase: N/A Priority: Normal
NCT ID: NCT00299494 Org: User:
Start: 05/04/06 End: 06/02/14 Due: 06/02/15

A Study Of PF-04447943 Compared To Placebo In Subjects With Mild To Moderate Alzheimer's Disease

Phase: N/A Priority: Normal
NCT ID: NCT00930059 Org: User:
Start: 09/10/09 End: 09/22/10 Due: 09/22/11

Impact of Prevnar 13 on Ear Infections in Children

Phase: N/A Priority: Normal
NCT ID: NCT01272999 Org: User:
Start: 05/21/10 End: 12/19/13 Due: 12/19/14

Correlation Between Beliefs About Medicine and Objective Measures of Efficacy and Safety in Rheumatoid Arthritis (RA)

Phase: N/A Priority: Normal
NCT ID: NCT01432366 Org: User:
Start: 10/31/10 End: 01/31/15 Due: 01/31/16

A Multicentre, Randomised, Open-Label Study To Compare The Efficacy And Safety Of Azithromycin For 5 Days With Those Of Amoxicillin-Clavulanic Acid In Patients With Chronic Bronchitis

Phase: N/A Priority: Normal
NCT ID: NCT00649831 Org: User:
Start: 10/31/02 End: 06/30/03 Due: 06/30/04

A Study to Understand is the COVID-19 Vaccine BNT162b2 is Safe in Indonesia People

Phase: N/A Priority: Normal
NCT ID: NCT05621239 Org: User:
Start: 03/15/23 End: 04/03/23 Due: 04/03/24

A Single-centre, Randomised, Double-blind, Placebo-controlled, Four Way Crossover Phase I Study to Investigate the Effect on QT/QTc Interval of Ceftazidime NXL104 or Ceftaroline Fosamil NXL104, Compared With Placebo, Using Moxifloxacin (Avelox®) as a Positive Control, in Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01290900 Org: User:
Start: 02/28/11 End: 05/31/11 Due: 05/31/12

12 Week Study Of PF-00734200 For The Treatment Of Type 2 Diabetes Mellitus In Subjects Treated With Metformin

Phase: N/A Priority: Normal
NCT ID: NCT00473525 Org: User:
Start: 07/31/07 End: 06/30/08 Due: 06/30/09

Single Dose Study Of PF-04308515 And Prednisone On Carbohydrate

Phase: N/A Priority: Normal
NCT ID: NCT01199029 Org: User:
Start: 08/31/10 End: 09/30/10 Due: 09/30/11

Elranatamab Expanded Access Protocol in Adults With Relapsed/Refractory Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT05462639 Org: User:
Start: - End: - Due: -